|
1
|
Davis ME: Epidemiology and Overview of
Gliomas. Semin Oncol Nurs. 34:420–429. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wesseling P and Capper D: WHO 2016
Classification of gliomas. Neuropathol Appl Neurobiol. 44:139–150.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bush NA, Chang SM and Berger MS: Current
and future strategies for treatment of glioma. Neurosurg Rev.
40:1–14. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ulitsky I and Bartel DP: lincRNAs:
Genomics, evolution, and mechanisms. Cell. 154:26–46. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sanchez Calle A, Kawamura Y, Yamamoto Y,
Takeshita F and Ochiya T: Emerging roles of long non-coding RNA in
cancer. Cancer Sci. 109:2093–2100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhan A, Soleimani M and Mandal SS: Long
Noncoding RNA and Cancer: A New Paradigm. Cancer Res. 77:3965–3981.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chaudhry MA: Expression pattern of small
nucleolar RNA host genes and long non-coding RNA in X-rays-treated
lymphoblastoid cells. Int J Mol Sci. 14:9099–9110. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ota T, Suzuki Y, Nishikawa T, Otsuki T,
Sugiyama T, Irie R, Wakamatsu A, Hayashi K, Sato H, Nagai K, et al:
Complete sequencing and characterization of 21,243 full-length
human cDNAs. Nat Genet. 36:40–45. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou Y, Tian B, Tang J, Wu J, Wang H, Wu
Z, Li X, Yang D, Zhang B, Xiao Y, et al: SNHG7: A novel vital
oncogenic lncRNA in human cancers. Biomed Pharmacother.
124:1099212020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ren J, Yang Y, Xue J, Xi Z, Hu L, Pan SJ
and Sun Q: Long noncoding RNA SNHG7 promotes the progression and
growth of glioblastoma via inhibition of miR-5095. Biochem Biophys
Res Commun. 496:712–718. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Carthew RW and Sontheimer EJ: Origins and
Mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang X, Zhao Y, Cao W, Wang C, Sun B, Chen
J, Li S, Chen J, Cui M, Zhang B, et al: miR-138-5p acts as a tumor
suppressor by targeting hTERT in human colorectal cancer. Int J
Clin Exp Pathol. 10:11516–11525. 2017.PubMed/NCBI
|
|
14
|
Ou L, Wang D, Zhang H, Yu Q and Hua F:
Decreased Expression of miR-138-5p by lncRNA H19 in Cervical Cancer
Promotes Tumor Proliferation. Oncol Res. 26:401–410. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 World Health Organization
Classification of Tumors of the Central Nervous System: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Δ Δ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Beermann J, Piccoli MT, Viereck J and Thum
T: Non-coding RNAs in Development and Disease: Background,
Mechanisms, and Therapeutic Approaches. Physiol Rev. 96:1297–1325.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Komori T: The 2016 WHO Classification of
Tumours of the Central Nervous System: The Major Points of
Revision. Neurol Med Chir (Tokyo). 57:301–311. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weller M, Wick W, Aldape K, Brada M,
Berger M, Pfister SM, Nishikawa R, Rosenthal M, Wen PY, Stupp R, et
al: Glioma. Nat Rev Dis Primers. 1:150172015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pop S, Enciu AM, Necula LG and Tanase C:
Long non-coding RNAs in brain tumours: Focus on recent epigenetic
findings in glioma. J Cell Mol Med. 22:4597–4610. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xi J, Sun Q, Ma L and Kang J: Long
non-coding RNAs in glioma progression. Cancer Lett. 419:203–209.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vecera M, Sana J, Lipina R, Smrcka M and
Slaby O: Long Non-Coding RNAs in Gliomas: From Molecular Pathology
to Diagnostic Biomarkers and Therapeutic Targets. Int J Mol Sci.
19:E27542018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zeng J, Ma YX, Liu ZH and Zeng YL: lncRNA
SNHG7 contributes to cell proliferation, invasion and prognosis of
cervical cancer. Eur Rev Med Pharmacol Sci. 23:9277–9285.
2019.PubMed/NCBI
|
|
25
|
Cheng D, Fan J, Ma Y, Zhou Y, Qin K, Shi M
and Yang J: lncRNA SNHG7 promotes pancreatic cancer proliferation
through ID4 by sponging miR-342-3p. Cell Biosci. 9:282019.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yao X, Liu C, Liu C, Xi W, Sun S and Gao
Z: lncRNA SNHG7 sponges miR-425 to promote proliferation,
migration, and invasion of hepatic carcinoma cells via
Wnt/β-catenin/EMT signalling pathway. Cell Biochem Funct.
37:525–533. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang Z, Wang P, Cao L, Li F, Duan S, Yuan
G, Xiao L, Guo L, Yin H, Xie D, et al: Long Intergenic Non-Coding
RNA 01121 Promotes Breast Cancer Cell Proliferation, Migration, and
Invasion via the miR-150-5p/HMGA2 Axis. Cancer Manag Res.
11:10859–10870. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fan Y, Li H, Yu Z, Dong W, Cui X, Ma J and
Li S: Long non-coding RNA FGD5-AS1 promotes non-small cell lung
cancer cell proliferation through sponging hsa-miR-107 to
up-regulate FGFRL1. Biosci Rep. 40:BSR201933092020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gan L, Yang Y, Li Q, Feng Y, Liu T and Guo
W: Epigenetic regulation of cancer progression by EZH2: From
biological insights to therapeutic potential. Biomark Res.
6:102018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gall Trošelj K, Novak Kujundzic R and
Ugarkovic D: Polycomb repressive complex's evolutionary conserved
function: The role of EZH2 status and cellular background. Clin
Epigenetics. 8:552016. View Article : Google Scholar
|
|
31
|
Liu Y, Sun J, Yu J, Ge W, Xiao X, Dai S
and Xiang Q: lncRNA CACS15 accelerates the malignant progression of
ovarian cancer through stimulating EZH2-induced inhibition of APC.
Am J Transl Res. 11:6561–6568. 2019.PubMed/NCBI
|
|
32
|
Xu M, Chen X, Lin K, Zeng K, Liu X, Xu X,
Pan B, Xu T, Sun L, He B, et al: lncRNA SNHG6 regulates EZH2
expression by sponging miR-26a/b and miR-214 in colorectal cancer.
J Hematol Oncol. 12:32019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhao L, Sun H, Kong H, Chen Z, Chen B and
Zhou M: The lncrna-TUG1/EZH2 Axis Promotes Pancreatic Cancer Cell
Proliferation, Migration and EMT Phenotype Formation Through
Sponging Mir-382. Cell Physiol Biochem. 42:2145–2158. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang K, Sun X, Zhou X, Han L, Chen L, Shi
Z, Zhang A, Ye M, Wang Q, Liu C, et al: Long non-coding RNA HOTAIR
promotes glioblastoma cell cycle progression in an EZH2 dependent
manner. Oncotarget. 6:537–546. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen Q, Cai J, Wang Q, Wang Y, Liu M, Yang
J, Zhou J, Kang C, Li M and Jiang C: Long Noncoding RNA NEAT1,
Regulated by the EGFR Pathway, Contributes to Glioblastoma
Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.
Clin Cancer Res. 24:684–695. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Wu L, Zhu X, Song Z, Chen D, Guo M, Liang
J, Ding D, Wang W and Yan D: Long Non-Coding RNA HOXA-AS2 Enhances
The Malignant Biological Behaviors In Glioma By Epigenetically
Regulating RND3 Expression. OncoTargets Ther. 12:9407–9419. 2019.
View Article : Google Scholar : PubMed/NCBI
|
